Novartis improves its 2024 outlook for the third time with Cosentyx

Swiss drugmaker Novartis on Tuesday raised its 2024 profit forecast for the third time amid greater use of its prescription drugs such as psoriasis and arthritis drug Cosentyx.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO